Epithelium/imcDC2 axis facilitates the resistance of neoadjuvant anti-PD-1 in human NSCLC.

J Immunother Cancer · 2024 · PMC11332012 · PMID 39134346

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

Single-cell RNA-seq further demonstrated enrichment of CD8+ TRMs in the TME of the Part-PR group, while CD69+ CD103− CD8+ T cells showed a decreasing trend ( online supplemental figure 5E–H ).

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.